PRHSX vs. PRWCX
Compare and contrast key facts about T. Rowe Price Health Sciences Fund (PRHSX) and T. Rowe Price Capital Appreciation Fund (PRWCX).
PRHSX is managed by T. Rowe Price. It was launched on Dec 29, 1995. PRWCX is managed by T. Rowe Price. It was launched on Jun 30, 1986.
Performance
PRHSX vs. PRWCX - Performance Comparison
Loading graphics...
PRHSX vs. PRWCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PRHSX T. Rowe Price Health Sciences Fund | -6.24% | 33.71% | 1.82% | 3.03% | -12.22% | 13.50% | 30.19% | 37.88% | 1.08% | 28.04% |
PRWCX T. Rowe Price Capital Appreciation Fund | -3.22% | 20.92% | 12.50% | 18.85% | -12.00% | 18.45% | 18.13% | 24.62% | 0.63% | 15.34% |
Returns By Period
In the year-to-date period, PRHSX achieves a -6.24% return, which is significantly lower than PRWCX's -3.22% return. Both investments have delivered pretty close results over the past 10 years, with PRHSX having a 11.84% annualized return and PRWCX not far behind at 11.41%.
PRHSX
- 1D
- 3.78%
- 1M
- -4.81%
- YTD
- -6.24%
- 6M
- 20.54%
- 1Y
- 27.86%
- 3Y*
- 10.42%
- 5Y*
- 5.52%
- 10Y*
- 11.84%
PRWCX
- 1D
- 1.91%
- 1M
- -2.92%
- YTD
- -3.22%
- 6M
- 5.51%
- 1Y
- 16.80%
- 3Y*
- 13.72%
- 5Y*
- 9.22%
- 10Y*
- 11.41%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PRHSX vs. PRWCX - Expense Ratio Comparison
PRHSX has a 0.80% expense ratio, which is higher than PRWCX's 0.68% expense ratio.
Return for Risk
PRHSX vs. PRWCX — Risk / Return Rank
PRHSX
PRWCX
PRHSX vs. PRWCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Sciences Fund (PRHSX) and T. Rowe Price Capital Appreciation Fund (PRWCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PRHSX | PRWCX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.13 | 1.27 | -0.14 |
Sortino ratioReturn per unit of downside risk | 1.93 | 2.37 | -0.44 |
Omega ratioGain probability vs. loss probability | 1.25 | 1.34 | -0.09 |
Calmar ratioReturn relative to maximum drawdown | 1.94 | 2.34 | -0.40 |
Martin ratioReturn relative to average drawdown | 5.86 | 9.70 | -3.83 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| PRHSX | PRWCX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.13 | 1.27 | -0.14 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.31 | 0.70 | -0.39 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.60 | 0.88 | -0.28 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.63 | 0.90 | -0.27 |
Correlation
The correlation between PRHSX and PRWCX is 0.70, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
PRHSX vs. PRWCX - Dividend Comparison
PRHSX's dividend yield for the trailing twelve months is around 25.66%, more than PRWCX's 16.24% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRHSX T. Rowe Price Health Sciences Fund | 25.66% | 24.06% | 12.89% | 5.21% | 1.77% | 7.46% | 7.16% | 12.29% | 6.57% | 7.43% | 4.55% | 11.34% |
PRWCX T. Rowe Price Capital Appreciation Fund | 16.24% | 15.72% | 10.38% | 4.15% | 9.44% | 9.23% | 7.97% | 5.83% | 7.46% | 6.82% | 3.51% | 9.86% |
Drawdowns
PRHSX vs. PRWCX - Drawdown Comparison
The maximum PRHSX drawdown since its inception was -42.96%, roughly equal to the maximum PRWCX drawdown of -41.77%. Use the drawdown chart below to compare losses from any high point for PRHSX and PRWCX.
Loading graphics...
Drawdown Indicators
| PRHSX | PRWCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.96% | -41.77% | -1.19% |
Max Drawdown (1Y)Largest decline over 1 year | -12.81% | -6.80% | -6.01% |
Max Drawdown (5Y)Largest decline over 5 years | -27.61% | -17.07% | -10.54% |
Max Drawdown (10Y)Largest decline over 10 years | -28.97% | -26.86% | -2.11% |
Current DrawdownCurrent decline from peak | -9.18% | -4.47% | -4.71% |
Average DrawdownAverage peak-to-trough decline | -8.75% | -3.34% | -5.41% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.24% | 1.64% | +2.60% |
Volatility
PRHSX vs. PRWCX - Volatility Comparison
T. Rowe Price Health Sciences Fund (PRHSX) has a higher volatility of 6.68% compared to T. Rowe Price Capital Appreciation Fund (PRWCX) at 3.64%. This indicates that PRHSX's price experiences larger fluctuations and is considered to be riskier than PRWCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| PRHSX | PRWCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.68% | 3.64% | +3.04% |
Volatility (6M)Calculated over the trailing 6-month period | 16.36% | 9.78% | +6.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.59% | 13.57% | +9.02% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.07% | 13.24% | +4.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.68% | 12.98% | +6.70% |